Timely care is an important dimension of health care quality, but the impact of delays in care
on lung cancer outcomes is unclear. Quantifying the impact of delays in cancer treatment on …

Background We aimed to identify the perception of physicians on the limitations and delays
for diagnosing, staging and treatment of lung cancer in Portugal. Methods Portuguese …

Background There is strong international evidence documenting inequities in cancer care
for migrant populations. In Australia, there is limited information regarding cancer equity for …

Background Most lung cancer is diagnosed at an advanced stage, resulting in poor survival.
This study examined diagnostic pathways for patients with operable lung cancer to identify …

Background Lung cancer is a major cause of morbidity and mortality worldwide. The
diagnosis of lung cancer is complex and can be easily missed or delayed. The aim of this …

Stage III non–small cell lung cancer (NSCLC) makes up a third of all NSCLC cases and is
potentially curable. Despite this 5‐year survival rates remain between 15% and 20% with …

Introduction: The impact of diagnosis and treatment delay on outcomes in advanced non-
small cell lung carcinoma (NSCLC) is not well understood. In this study, we examined the …

Aims Delays in lung cancer diagnosis and treatment can impact survival. We explored
reasons for delays experienced by patients with lung cancer to identify themes and …

Rak płuca zajmuje szczególne miejsce w świadomości społecznej. Zabiera życie większej
liczbie osób niż jakikolwiek inny nowotwór, ale ponieważ choroba jest tak ściśle związana z …

Background: Lung cancer is a major cause of morbidity and mortality worldwide. The
diagnosis of lung cancer is complex and can be easily missed or delayed. The aim of this …